New supplies of two currently hard-to-find cancer drugs are on the way, according to the FDA. As Dow Jones Newswires reports, the FDA said it would allow the temporary importation of Lipodox, made by Sun Pharma Global FZE and distributed by Caraco Pharmaceutical Laboratories.
Federal health officials said there will be enough supply of a children’s leukemia drug released in the next couple of weeks to alleviate a shortage.
Roche and Genentech have been informed that a counterfeit product, labeled as Avastin (bevacizumab), has been distributed in the United States. The counterfeit product is not safe or effective and should not be used. Chemical analyses of the counterfeit vials tested to date have confirmed the product does not contain the active ingredients for Avastin.
Nearly 3.6 million people with Medicare saved $2.1 billion on their prescription drugs in 2011 thanks to the Affordable Care Act according to data issued today by the Department of Health and Human Services (HHS). Savings for people with Medicare will increase over time.
In comments submitted on January 31, 2012, NCCS offered advice to the Department of Health and Human Services (HHS) regarding the definition of essential health benefits (EHB) that must be offered by most individual and small employer health plans and certain public plans.
NCCS joined 18 other national cancer patient, professional, and research organizations in recommending modifications to the essential health benefits plan proposed by the Department of Health and Human Services (HHS).
Connect with us:
Facebook Twitter YouTube RSSCopyright © 1995-2012 by the National Coalition for Cancer Survivorship
1010 Wayne Avenue, Suite 770 · Silver Spring, MD 20910 · 877-NCCS-YES · info@canceradvocacy.org